A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

In 2025, newly-designed clinical trials for people with cancer are providing new options and hope for patients and their ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

By using a compound derived from a Himalayan fungus and used for centuries in Chinese medicine as a jumping off point, ...

Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an inordinate number of debates about the clinical value of phase 1 trials.“I’ve argued for a long time that for phase 1 ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...

Additional clinical data from trials in colorectal cancer, lymphoma ... a novel EGFR-targeted antibody-drug conjugate, into Phase 1 trials expected to begin mid-2025. Currently, ALXO is trading ...

In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...